‘LANXESS CMIT/MIT biocidal product family’ contains ‘mixture of 5-chloro-2-methyl-2H-isothiazol-3-one and 2-methyl-2H-isothiazol-3-one (3:1) (Mixture of CMIT/MIT)’ as the active substance, included in the Union list of approved active substances referred to in Article 9(2) of Regulation (EU) No 528/2012 for product-types 6, 11, 12 and 13.
Recital 2, Regulation (EU) 2024/2750
In forcesince 25 Oct 2024